
Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

